Abstract
Glutamatergic neurotransmission has been shown to be dysregulated in bipolar disorder (BD), alcohol use disorder (AUD) and substance use disorder (SUD). Similarly, disruption in the hypothalamic-pituitary-adrenal (HPA)-axis has also been observed in these conditions. BD is often comorbid with AUD and SUD. The effects of the glutamatergic and HPA systems have not been extensively examined in individuals with BD-AUD and BD-SUD comorbidity. The aim of this investigation was to determine whether variants in the glutamatergic pathway and HPA-axis are associated with BD-AUD and BD-SUD comorbidity. The research cohort consisted of 498 individuals with BD type I from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). A subset of the cohort had comorbid current AUD and current SUD. A total of 1935 SNPs from both the glutamatergic and HPA pathways were selected from the STEP-BD genome-wide dataset. To identify population stratification, IBS clustering was performed using the program Plink 1.07. Single SNP association and gene-based association testing were conducted using logistic regression. A pathway analysis of glutamatergic and HPA genes was performed, after imputation using IMPUTE2. No single SNP was associated with BD-AUD or BD-SUD comorbidity after correction for multiple testing. However, from the gene-based analysis, the gene PRKCI was significantly associated with BD-AUD. The pathway analysis provided overall negative findings, although several genes including GRIN2B showed high percentage of associated SNPs for BD-AUD. Even though the glutamatergic and HPA pathways may not be involved in BD-AUD and BD-SUD comorbidity, PRKCI deserves further investigation in BD-AUD.
Similar content being viewed by others
References
Altamura A, Boin F, Maes M (1999) HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur Neuropsychopharmacol 10:1–4
Chang Y, Lee S, Chen S, Tzeng N, Wang T, Hui Lee I, See Chen P, Huang S, Kuang Yang Y, Ko H (2013) Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. J Affect Disord 151:967–972
Das J, Pany S, Rahman G, Slater S (2009) PKClunate epsilon has an alcohol-binding site in its second cysteine-rich regulatory domain. Biochem J 421:405–413
Drago A, Crisafulli C, Sidoti A, Serretti A (2011) The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes. Prog Neurobiol 94:418–460
Etain B, Rousseva A, Roy I, Henry C, Malafosse A, Buresi C, Preisig M, Rayah F, Leboyer M, Bellivier F (2004) Lack of association between 5HT2A receptor gene haplotype, bipolar disorder and its clinical subtypes in a west European sample. Am J Med Genet B Neuropsychiatr Genet 129:29–33
Faul F, Erdfelder E, Lang A, Buchner A (2007) G* power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191
Gotlib IH, Joormann J, Minor KL, Hallmayer J (2008) HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol Psychiatry 63:847–851
Greenwood TA, Kelsoe JR, Bipolar Genome Study (BiGS) Consortium (2013) Genome-wide association study of irritable vs. elated mania suggests genetic differences between clinical subtypes of bipolar disorder. PLoS One 8:e53804
Grover D, Verma R, Goes FS, Mahon PLB, Gershon ES, McMahon FJ, Potash JB (2009) Family-based association of YWHAH in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 150:977–983
Hahn C, Friedman E (1999) Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1:81–86
Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis. Trends Neurosci 20:78–84
Holliday KL, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J (2010) Genetic variation in the hypothalamic-pituitary-adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study. Ann Rheum Dis 69:556–560
Hsieh MH, Tang C, Hung S, Lee IH, Lin Y, Yang YK (2012) Comorbid prevalence of alcohol dependence, substance abuse, and external cause of injury in patients with bipolar disorder in a nationwide representative sample in Taiwan. Bipolar Disord 14:677–679
Huizink AC, Ferdinand RF, Ormel J, Verhulst FC (2006) Hypothalamic–pituitary–adrenal axis activity and early onset of cannabis use. Addiction 101:1581–1588
Iwamoto K, Ueda J, Bundo M, Kojima T, Kato T (2011) Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders. Neurosci Res 70:238–242
Joslyn G, Ravindranathan A, Brush G, Schuckit M, White RL (2010) Human variation in alcohol response is influenced by variation in neuronal signaling genes. Alcohol Clin Exp Res 34:800–812
Kandaswamy R, McQuillin A, Curtis D, Gurling H (2014) Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 165:365–372
Keller PA, McCluskey A, Morgan J, O'Connor SM (2006) The role of the HPA axis in psychiatric disorders and CRF antagonists as potential treatments. Arch Pharm (Weinheim) 339:346–355
Kerner B, Lambert CG, Muthen BO (2011) Genome-wide association study in bipolar patients stratified by co-morbidity. PLoS One 6:e28477
Kim JH, Park M, Yang SY, Jeong BS, Yoo HJ, Kim J, Chung J, Kim S (2006) Association study of polymorphisms in N-methyl-d-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism. Neurosci Res 56:220–223
Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan KH, Janavs J, Dunbar G (1997) The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry 12:224–231
Lee H, Woo HG, Greenwood TA, Kripke DF, Kelsoe JR (2013) A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorder. J Affect Disord 145:200–207
Le-Niculescu H, Patel S, Bhat M, Kuczenski R, Faraone S, Tsuang M, McMahon F, Schork N, Nurnberger Jr J, Niculescu III A (2008) Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms
Leszczyńska-Rodziewicz A, Maciukiewicz M, Szczepankiewicz A, Pogłodziński A, Hauser J (2013) Association between OPCRIT dimensions and polymorphisms of HPA axis genes in bipolar disorder. J Affect Disord 151:744–747
Leszczyńska-Rodziewicz A, Szczepankiewicz A, Narożna B, Skibińska M, Pawlak J, Dmitrzak-Węglarz M, Hauser J (2014) Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder. Neuropsychiatr Dis Treat 10:243–248
Lett TA, Zai CC, Tiwari AK, Shaikh SA, Likhodi O, Kennedy JL, Müller DJ (2011) ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype. World J Biol Psychiatry 12:392–397
Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373:234–239
Manenschijn L, Spijker AT, Koper JW, Jetten AM, Giltay EJ, Haffmans J, Hoencamp E, van Rossum EF (2012) Long-term cortisol in bipolar disorder: associations with age of onset and psychiatric co-morbidity. Psychoneuroendocrinology 37:1960–1968
Manji HK, Lenox RH (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46:1328–1351
McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH (2007) Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127:108–118
McElroy SL, Altshuler LL, Suppes T, Keck Jr PE, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR (2001) Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158:420–426
McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A (2003) The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60:497–502
McIntyre RS, Nguyen HT, Soczynska JK, Lourenco MT, Woldeyohannes HO, Konarski JZ (2008) Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities. Dialogues Clin Neurosci 10:203–213
Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68:241–251
Müller-Oerlinghausen B, Berghöfer A, Bauer M (2002) Bipolar disorder. Lancet 359:241–247
Muráni E, Ponsuksili S, D'Eath RB, Turner SP, Kurt E, Evans G, Thölking L, Klont R, Foury A, Mormède P (2010) Association of HPA axis-related genetic variation with stress reactivity and aggressive behaviour in pigs. BMC Genet 11:74
Nery FG, Stanley JA, Chen H, Hatch JP, Nicoletti MA, Serap Monkul E, Lafer B, Soares JC (2010) Bipolar disorder comorbid with alcoholism: a 1 H magnetic resonance spectroscopy study. J Psychiatr Res 44:278–285
Nishizuka Y (1989) The family of protein kinase C for signal transduction. JAMA 262:1826–1833
Nurnberger JI, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I, Vawter MP, Kelsoe JR (2014) Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 71:657–664
Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464–468
Prata DP, Breen G, Osborne S, Munro J, St Clair D, Collier DA (2009) An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis. Psychiatr Genet 19:113–116
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, De Bakker PI, Daly MJ (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E (2003) Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 53:1028–1042
Salloum IM, Thase ME (2000) Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2:269–280
Sanacora G, Zarate CA, Krystal JH, Manji HK (2008) Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 7:426–437
Saunders EH, Scott LJ, McInnis MG, Burmeister M (2008) Familiality and diagnostic patterns of subphenotypes in the national institutes of mental health bipolar sample. Am J Med Genet B Neuropsychiatr Genet 147:18–26
Saunders EF, Zhang P, Copeland JN, Mclnnis MG, Zöllner S (2009) Suggestive linkage at 9p22 in bipolar disorder weighted by alcohol abuse. Am J Med Genet B Neuropsychiatr Genet 150:1133–1138
Schatzberg A, Keller J, Tennakoon L, Lembke A, Williams G, Kraemer F, Sarginson J, Lazzeroni L, Murphy G (2013) HPA axis genetic variation, cortisol and psychosis in major depression. Mol Psychiatry 19:220–227
Schulze TG (2010) Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization. Psychiatr Clin North Am 33:67–82
Sharpe AL, Phillips TJ (2009) Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav Pharmacol 20:346–351
Shi J, Badner JA, Hattori E, Potash JB, Willour VL, McMahon FJ, Gershon ES, Liu C (2008) Neurotransmission and bipolar disorder: a systematic family-based association study. Am J Med Genet B Neuropsychiatr Genet 147:1270–1277
Sjoholm LK, Kovanen L, Saarikoski ST, Schalling M, Lavebratt C, Partonen T (2010) CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. J Circadian Rhythms 8:1. doi:10.1186/1740-3391-8-1
Sklar P, Smoller J, Fan J, Ferreira M, Perlis R, Chambert K, Nimgaonkar V, McQueen M, Faraone S, Kirby A (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13:558–569
Smith ML, Li J, Ryabinin AE (2014) Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain. Alcohol Alcohol
Szczepankiewicz A, Dmitrzak-Weglarz M, Skibinska M, Slopien A, Leszczynska-Rodziewicz A, Czerski P, Hauser J (2007) Study of dopamine receptors genes polymorphisms in bipolar patients with comorbid alcohol abuse. Alcohol Alcohol 42:70–74
Thayer JF, Hall M, Sollers III JJ, Fischer JE (2006) Alcohol use, urinary cortisol, and heart rate variability in apparently healthy men: evidence for impaired inhibitory control of the HPA axis in heavy drinkers. Int J Psychophysiol 59:244–250
Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M, Saam C, Lascorz J, Soyka M, Preuss U (2006) Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11:594–602
Vergara VM, Ulloa A, Calhoun VD, Boutte D, Chen J, Liu J (2014) A three-way parallel ICA approach to analyze links among genetics, brain structure and brain function. Neuroimage
Walker E, Mittal V, Tessner K (2008) Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 4:189–216
Wang H, Friedman E (1996) Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 40:568–575
Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH (2004) Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184:496–502
Wetherell MA, Montgomery C (2014) Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users. Psychopharmacology 231:1365–1375
Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA (2006) DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum Mol Genet 15:743–749
Xu W, Cohen-Woods S, Chen Q, Noor A, Knight J, Hosang G, Parikh SV, De Luca V, Tozzi F, Muglia P (2014) Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med Genet 15:2
Yasseen B, Kennedy JL, Zawertailo LA, Busto UE (2010) Comorbidity between bipolar disorder and alcohol use disorder: association of dopamine and serotonin gene polymorphisms. Psychiatry Res 176:30–33
Zhao Q, Che R, Zhang Z, Wang P, Li J, Li Y, Huang K, Tang W, Feng G, Lindpaintner K (2011) Positive association between GRIN2B gene and bipolar disorder in the Chinese Han population. Psychiatry Res 185:290–292
Acknowledgments
The authors acknowledge the support of the National Research Foundation (NRF), the Medical Research Council of South Africa and the University of Cape Town (UCT). The authors declare no conflict of interest.
The STEP-BD project was funded in whole or in part with Federal Funds from the National Institute of Mental Health (NIMH), under contract N01MH8001.
Collection of DNA from consenting participants in STEP-BD was supported by N01MH80001 (Gary S. Sachs, M.D., principal investigator). Sample collection funding was supported by NIH grants (MH067288, Pamela Sklar; MH063445, Jordan W. Smoller; MH63420, Vish Nimgaonkar). Genotyping was funded by grants from NIH (MH067288 Pamela Sklar, PI), Johnson & Johnson Pharmaceutical Research and Development, Sylvan C. Herman Foundation, Stanley Medical Research Foundation, and Merck Genome Research Institute (Edward Scolnick, PI).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dalvie, S., Fabbri, C., Ramesar, R. et al. Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders. Metab Brain Dis 31, 183–189 (2016). https://doi.org/10.1007/s11011-015-9762-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-015-9762-1